Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
of how you plan to contribute to Bio2Q. (4) Recommendation letter(s) *Please see the materials below for more details. [Call for a Postdoctoral Fellow for Proteostasis Lab (PI Nadinath Nillegoda, PhD
-
Introduction to Westlake University: Westlake University is a new type of high-quality research-oriented university based in the historic city of Hangzhou, China. Our university was founded by prominent globally respected scientists and scholars. At Westlake, we emphasize academic freedom,...
-
At the laboratory of Associate Professor Kumar Somyajit, we seek a highly motivated PhD student with strong background in cell biology and prime interest in cell cycle, genome maintenance, cancer
-
applications for PhD research fellowship position(s) within the field of machine learning, AI Safety, and mechanistic interpretability, to be filled earliest by 1 January 2026 for a period of three years
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
publications Co-supervision and scientific support of PhD and master’s students Your profile Required qualifications: PhD degree in Bioinformatics, Artificial Intelligence, Biochemistry, Biophysics
-
have obtained a PhD degree within the last 10 years. Please submit the following documents to the ICYS Recruitment Desk by March 24, 2026 JST: CV Application form including a research proposal for ICYS
-
chosen to remain at Scripps Research to build their independent careers. QUALIFICATIONS Candidates must have a recently (< 1 year) received a PhD, MD, DVM or equivalent in a relevant discipline, and have
-
) provides an outstanding multidisciplinary environment that underpins the BHF Centre’s research strengths. SCMMS hosts more than 65 academic groups and around 400 staff and 110 PhD students, spanning
-
with therapeutic response and resistance to RAS inhibition in non-small cell lung cancer (NSCLC) in the laboratory of Ferdinandos Skoulidis, MD, PhD, at the University of Texas MD Anderson Cancer Center